Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Internal Medicine
•
Neurology
How do you transition from Levetiracetam to Brivaracetam, particularly at doses of 1500 mg BID or higher?
Related Questions
How do you manage follow-up lab findings of hyperchloremic metabolic acidosis and low bicarbonate in patients on zonisamide or topiramate?
What recommendations would you make for a patient on long-term phenytoin due to epilepsy with a newly diagnosed breast cancer requiring doxorubicin as part of her chemotherapy?
What are the most significant drug interactions you consider when using cenobamate and would you ever consider using cenobamate as monotherapy?
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
When do you consider ketamine to treat nonconvulsive status epilepticus?
Do you warn patients about suicidal ideation when starting anti-seizure medications?
How do you approach use of newer anti-seizure medications for epilepsy patients on DOACs?
What are your preferred anti-seizure medications in Doose syndrome?
If a patient who has previously been taking lamotrigine stops taking it for between two weeks and a month, do you have to uptitrate it all over again or do you have another way to resume it?
How do you counsel patients with epilepsy who are interested in purchasing a seizure dog?
